市場調査レポート

マウスモデルの世界市場 (モデルタイプ別、専門別、サービス別、地域別):2015〜2023年の予測

Mice Model Market (by Model Type, by Specialty, by Services, and by Geography): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

発行 Transparency Market Research 商品コード 339868
出版日 ページ情報 英文 155 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
マウスモデルの世界市場 (モデルタイプ別、専門別、サービス別、地域別):2015〜2023年の予測 Mice Model Market (by Model Type, by Specialty, by Services, and by Geography): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
出版日: 2015年09月03日 ページ情報: 英文 155 Pages
概要

マウスは高度化した遺伝子ツールと重要な遺伝資源をもつ哺乳動物であることからよく用いられるモデルシステムです。免疫不全のヒト化したマウスなどの新規モデルの導入によって、マウスをモデルとしてヒトの病態生理学や病気進行の研究、および薬剤開発はさらに広がっていくものとみられています。遺伝子の99%がヒトと共通であるため、遺伝子検査に新たな可能性が広がっています。

当レポートでは、世界のマウスモデル市場について調査し、市場の概要と2023年までの予測、モデルタイプ、用途、サービスおよび地域別動向、および主要企業のプロファイルをまとめています。

第1章 序論

第2章 エグゼクティブサマリー

第3章 世界のマウスモデル市場概要

  • 概要
  • マウスモデルのエンドユーザー
  • 市場動向
    • 促進因子
      • 生物医学研究への投資拡大
      • 2007〜2012年の生物医学研究の成長率
      • 進化したマウスモデルの増加が用途や受容性を拡大
      • マウスモデルの個別化in vivo解析により個別化医療におけるマウスモデルの需要を促進
    • 市場阻害因子
      • 世界の動物モデル使用に対する懸念が市場を抑制
      • 代替技術の発展
    • 機会
      • アジア諸国がマウスモデル市場における大きな成長の機会に
  • イベント影響評価
  • 市場魅力度分析
  • 競合環境

第4章 タイプ別市場

  • 概要
  • トランスジェニックマウスモデル
  • ハイブリッド/コンジェニックマウスモデル
  • ノックアウトマウスモデル
  • 発癌物質誘発・自然発症マウスモデル
  • 非近交系マウスモデル
  • 近交系マウスモデル
  • 移植マウスモデル
  • 調整/外科的修飾マウスモデル

第5章 専門性別

  • 概要
  • 免疫学
  • 中枢神経系
  • 腫瘍学
  • 心血管
  • 糖尿病
  • 代謝/調節性

第6章 サービス別市場

  • 概要
  • 出血・再導出サービス
  • 凍結保存・回収サービス
  • 検疫サービス
  • 遺伝子試験サービス

第7章 地域別市場

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・北アフリカ
  • その他

第8章 提言

第9章 企業プロファイル

  • Charles River Laboratories International, Inc
  • Crescendo Biologics Limited
  • Deltagen, Inc.
  • genOway S.A.
  • Harbour Antibodies BV
  • Harlan Laboratories, Inc.
  • ImmunoGenes AG
  • SAGE Labs
  • The Jackson Laboratory
  • Taconic Biosciences, Inc.
  • TransGenic, Inc

図表

目次

Mouse is a popular model system because it is a mammal with sophisticated genetic tools and significant genetic resources. The prospect of the mice as a model for exploring human pathophysiology and disease progression and for developing drugs is likely to be further widened by the introduction of new models such as immunedeficient and humanizing mouse in which human tissues and cells or genes are reconstituted. With 99% of their genes shared with humans, new possibilities were opened for genetic testing. Furthermore, the conservation of genetic association within the mice and human genomes with respect to the encoded genes and their alignment along chromosomes has been a great advantage in the identification of potentially conforming homologous mutations and disease genes.

This report studies the global mice model market from five perspectives: by type of model, application, services, and geography. Based on type of model, the market has been segmented into hybrid/congenic, transplantation mouse, transgenic, knockout, carcinogen-induced and spontaneous mouse, outbred, inbred, and conditioned/surgically modified. Based on application, the market has been segmented into immunology, central nervous system, oncology, cardiovascular, diabetes, and metabolism & regulation. Some of the prominent services offered to end-users include breeding and rederivation, cryopreservation and cryorecovery, quarantine services, genetic testing, model in-licensing, in vivo and in vitro pharmacology services, genetically engineered model services and other services such as surgical and line rescue. Geographically, the market has been studied and estimated for six regions: North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World.

The market overview section of the report demonstrates major market dynamics such as drivers, restraints, and opportunities that influence the current and future status of the industry. The market overview section includes market attractiveness analysis by geography coupled with qualitative analysis on regulatory scenarios, and impact analysis of key industry events to provide a thorough analysis of the overall competitive scenario in the global mice model market. The market overview section of the report also includes the qualitative and quantitative analysis of the competitive landscape.

Market share analysis is also provided in the market overview section of the report for 2014 in terms of value (%). The report also provides important recommendations for market players and new entrants. These recommendations would enable existing market players to expand their market share and help new companies establish their presence in the mice model market across the globe. The report concludes with the company profiles section, which includes key information about major players in the market such as financial overview, business strategies, and recent developments. Key players mentioned in the report include Charles River Laboratories, Crescendo Biologics Limited, Deltagen, Inc., GenOway S.A., Harlan Laboratories, Inc., ImmunoGenes AG, Taconic Biosciences, Inc., Lexicon Pharmaceuticals, SAGE Labs, The Jackson Laboratory, Taconic Biosciences, Inc., and TransGenic, Inc.

The global mice model market is segmented into the following categories:

Global Mice Model Market, by Type

  • Transgenic Mice Model
  • Hybrid/Congenic Mice Model
  • Knockout Mice Model
  • Carcinogen-induced and Spontaneous Mice Model
  • Outbred Mice Model
  • Inbred Mice Model
  • Transplantation Mice Model
  • Conditioned/Surgically Modified Mice Model

Global Mice Model Market, by Specialty

  • Immunology
  • Central Nervous System (CNS)
  • Oncology
  • Cardiovascular
  • Diabetes
  • Metabolism & Regulation

Global Mice Model Market, by Services

  • Breeding and Rederivation Services
  • Cryopreservation and Cryorecovery Services
  • Quarantine Services
  • Genetic Testing Services
  • Model In-licensing Services
  • In vivo and In vitro Pharmacology Services
  • Genetically Engineered Model Services
  • Other Services (Surgical and Line Rescue)

Global Mice Model Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific (APAC)
    • Japan
    • China
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & North Africa (MENA)
    • Saudi Arabia
    • UAE
    • Israel
    • Rest of MENA
  • Rest of the World (RoW)

Table of Contents

Chapter 1 - Introduction

  • 1.1. Report Description
  • 1.2. Research Methodology
    • 1.2.1. Secondary Research
    • 1.2.2. Primary Research
  • 1.3. Market Segmentation
  • 1.4. Assumptions and Stipulations

Chapter 2 - Executive Summary

  • 2.1. Global Mice Consumption, 2013
  • 2.2. Market Snapshot: Global Mice Model Market (2014 and 2023E)
  • 2.3. Global Mice Model Market, by Type, 2014 (USD Million)
  • 2.4. Global Mice Model Market, by Application, 2014 (USD Million)
  • 2.5. Global Mice Model Market, by Services, 2014 (USD Million)
  • 2.6. Comparative Analysis: Global Mice Model Market Revenue, by Geography, 2014 and 2023E (Value %)

Chapter 3 - Global Mice Model Market: Market Overview

  • 3.1. Overview
    • 3.1.1. Proportion of Mice as Compared to Total Animal Used in Research Globally (Value %), 2011
  • 3.2. End-users of Mice Models
    • 3.2.1. End-user Analysis of Mice Model Market (Value %), 2013
  • 3.3. Market Dynamics
    • 3.3.1. Drivers
      • 3.3.1.1. Growing investment in biomedical research
      • 3.3.1.2. Biomedical Research Growth Rate, 2007-2012, (%)
      • 3.3.1.3. Growing number of advanced mice model would increase applicability and acceptability
      • 3.3.1.4. Personalized in vivo analysis mice models would fuel demand for mice models in personalized medicine
    • 3.3.2. Restraints
      • 3.3.2.1. Rising concern about animal use across the globe would restrain the market
      • 3.3.2.2. Development of alternative technologies
    • 3.3.3. Opportunities
      • 3.3.3.1. Countries in Asia offer immense growth opportunities in the mice model market
  • 3.4. Event Impact Assessment: Mice Model Market
  • 3.5. Market Attractiveness Analysis: Global Mice Model Market
    • 3.5.1. Mice Model Market Analysis: The U.S. and China
    • 3.5.2. Market Attractiveness Analysis: Global Mice Model Market, by Geography
    • 3.5.3. Growth-Share Matrix Analysis: Global Mice Model Market, by Type
  • 3.6. Competitive Landscape
    • 3.6.1. Global Market Share Analysis, by Key Players, 2013 (Value %)
    • 3.6.2. Global Market Share Analysis, by Key Players, 2014 (Value %)
    • 3.6.3. Heat Map Analysis, by Key Geography, 2014 (Market Share)
    • 3.6.4. Heat Map Analysis, by Key Geography, 2014 (Market Growth)

Chapter 4 - Global Mice Model Market, by Type

  • 4.1. Overview
    • 4.1.1. Global Mice Model Market, by Type, 2013-2014 (USD Million)
    • 4.1.2. Global Mice Model Market, by Model Type, 2015E-2023E (USD Million)
  • 4.2. Transgenic Mice Model
    • 4.2.1. Transgenic Mice Applications in Various Specialties (%)
    • 4.2.2. Global Transgenic Mice Model Market, 2013-2023E (USD Million)
  • 4.3. Hybrid/Congenic Mice Model
    • 4.3.1. Global Hybrid/Congenic Mice Model Market, 2013-2023E (USD Million)
  • 4.4. Knockout Mice Model
    • 4.4.1. Knockout Mice Applications in Various Specialties, 2014 (%)
    • 4.4.2. Global Knockout Mice Model Market, 2013-2023E (USD Million)
  • 4.5. Carcinogen-induced and Spontaneous Mice Model
    • 4.5.1. Global Carcinogen-induced and Spontaneous Mice Model Market, 2013-2023E (USD Million)
  • 4.6. Outbred Mice Model
    • 4.6.1. Global Outbred Mice Model Market, 2013-2023E (USD Million)
  • 4.7. Inbred Mice Model
    • 4.7.1.1. Inbred Mice Applications in various Specialties (%), 2014
    • 4.7.1.2. Global Inbred Mice Model Market, 2013-2023E (USD Million)
  • 4.8. Transplantation Mice Model
    • 4.8.1. Global Transplantation Mice Model Market, 2013-2023E (USD Million)
  • 4.9. Conditioned/Surgically Modified Mice Model
    • 4.9.1. Global Conditioned/Surgically Modified Mice Model Market, 2013-2023E (USD Million)

Chapter 5 - Global Mice Model Market, by Specialty

  • 5.1. Overview
    • 5.1.1. Global Mice Model Market, by Application, 2013-2014 (USD Million)
    • 5.1.2. Global Mice Model Market, by Application, 2015E-2023E (USD Million)
  • 5.2. Immunology
    • 5.2.1. Global Immunology Mice Model Market, 2013-2023E (USD Million)
    • 5.2.2. Number of Immunology Mice Models, by Major Companies
    • 5.2.3. Immunology Mice Model Market Share, by Model Type, 2014
  • 5.3. Central Nervous System (CNS)
    • 5.3.1. Global CNS Mice Model Market, 2013-2023E (USD Million)
    • 5.3.2. Number of CNS Mice Models, by Major Companies
    • 5.3.3. CNS Mice Model Market Share, by Model Type, 2014
  • 5.4. Oncology
    • 5.4.1. Global Oncology Mice Model Market, 2013-2023E (USD Million)
    • 5.4.2. Number of Oncology Mice Models, by Major Companies
    • 5.4.3. Oncology Mice Model Market Share, by Model Type, 2014
  • 5.5. Cardiovascular
    • 5.5.1. Global Cardiovascular Mice Model Market, 2013-2023E (USD Million)
    • 5.5.2. Number of Cardiovascular Mice Models, by Major Companies
    • 5.5.3. Cardiovascular Mice Model Market Share, by Model Type, 2014
  • 5.6. Diabetes
    • 5.6.1. Global Diabetes Mice Model Market, 2013-2023E (USD Million)
    • 5.6.2. Number of Diabetes Mice Models, by Major Companies
    • 5.6.3. Diabetes Mice Model Market Share, by Model Type, 2014
  • 5.7. Metabolism & Regulation
    • 5.7.1. Global Metabolism & Regulation Mice Model Market, 2013-2023E (USD Million)
    • 5.7.2. Metabolism & Regulation Mice Models Market Share, by Model Type, 2014

Chapter 6 - Global Mice Model Market, by Services

  • 6.1. Overview
    • 6.1.1. Global Mice Model Market, by Services, 2013-2014 (USD Million)
    • 6.1.2. Global Mice Model Market, by Services, 2015E-2023E (USD Million)
  • 6.2. Breeding and Rederivation Services
    • 6.2.1. Global Breeding and Rederivation Services Market, 2013-2023E (USD Million)
  • 6.3. Cryopreservation and Cryorecovery Services
    • 6.3.1. Global Cryopreservation and Cryorecovery Services Market, 2013-2023E (USD Million)
  • 6.4. Quarantine Services
    • 6.4.1. Global Quarantine Services Market, 2013-2023E (USD Million)
  • 6.5. Genetic Testing Services
    • 6.5.1. Global Genetic Testing Services Market, 2013-2023E (USD Million)
  • 6.6. Model In-licensing Services
    • 6.6.1. Global Model In-licensing Market, 2013-2023E (USD Million)
  • 6.7. In vivo and In vitro Pharmacology Services
    • 6.7.1. Global In vivo and In vitro Pharmacology Services Market, 2013-2023E (USD Million)
  • 6.8. Genetically Engineered Model Services
    • 6.8.1. Genetically Engineered Model Services
  • 6.9. Other Services (Surgical and Line Rescue)
    • 6.9.1. Global Other Services Market, 2013-2023E (USD Million)

Chapter 7 - Global Mice Model Market, by Geography

  • 7.1. Overview
    • 7.1.1. Mice Model Market Share Index, 2014 (On Scale of 1 to 5)
    • 7.1.2. Global Mice Model Market, Growth Index, 2015-2023 (On a Scale of 1 to 5)
    • 7.1.3. Global Mice Model Market Revenue, by Geography, 2013-2023 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Population, GDP, and Health care Expenditure, 2011-2013
    • 7.2.2. North America Mice Model Market Revenue, 2013-2023E (USD Million
    • 7.2.3. U.S.
      • 7.2.3.1. U.S. Mice Model Market, 2013-2023E (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Comparative Analysis: Proportion of Animals Used in Research in Canada, 2011 and 2012 (Value %)
      • 7.2.4.2. Canada Mice Model Market, 2013-2023E (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Population, GDP, and Health care Expenditure, 2011-2013
    • 7.3.2. Europe Mice Model Market Revenue, 2013-2023E (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Mice Model Market Revenue, 2013-2023E (USD Million)
    • 7.3.4. U.K.
      • 7.3.4.1. U.K. Mice Model Market Revenue, 2013-2023E (USD Million)
    • 7.3.5. Rest of Europe
      • 7.3.5.1. Rest of Europe Mice Model Market Revenue, 2013-2023E (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Population, GDP, and Healthcare Expenditure, 2011-2013
    • 7.4.2. Asia Pacific Mice Model Market Revenue, 2013-2023E (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Mice Model Market, 2013-2023E (USD Million)
    • 7.4.4. China
      • 7.4.4.1. China Mice Model Market, 2013-2023E (USD Million)
    • 7.4.5. Rest of Asia Pacific
      • 7.4.5.1. Rest of Asia Pacific Mice Model Market, 2013-2023E (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Population, GDP, and Health care Expenditure, 2011 - 2013
    • 7.5.2. Latin America Mice Model Market, 2013-2023E (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Brazil Mice Model Market, 2013-2023E (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Mexico Mice Model Market, 2013-2023E (USD Million)
    • 7.5.5. Rest of Latin America
      • 7.5.5.1. Rest of Latin America Mice Model Market, 2013-2023E (USD Million)
  • 7.6. Middle East & North Africa (MENA)
    • 7.6.1. MENA Mice Model Market, 2013-2023E (USD Million)
    • 7.6.2. Saudi Arabia (KSA)
      • 7.6.2.1. Saudi Arabia Mice Model Market, 2013-2023E (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Mice Model Market, 2013-2023E (USD Million)
    • 7.6.4. Israel
      • 7.6.4.1. Israel Mice Model Market, 2013-2023E (USD Million)
    • 7.6.5. Rest of MENA
      • 7.6.5.1. Rest of MENA Mice Model Market, 2013-2023E (USD Million)
  • 7.7. Rest of the World (RoW)
    • 7.7.1. RoW Population, GDP, and Health care Expenditure, 2011-2013
    • 7.7.2. Rest of World Mice Model Market, 2013-2023E (USD Million)

Chapter 8 - Recommendations

  • 8.1. Focus on collaborations with contract research organizations or strengthening in-house research capabilities
  • 8.2. Sustaining pricing pressures in a declining global economic scenario
  • 8.3. Investing in emerging markets such as India, China, and Brazil

Chapter 9 - Company Profiles

  • 9.1. Charles River Laboratories International, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Financial Overview
    • 9.1.3. Product Portfolio
    • 9.1.4. Business Strategies
    • 9.1.5. Recent Developments
  • 9.2. Crescendo Biologics Limited
    • 9.2.1. Company Overview
    • 9.2.2. Financial Overview
    • 9.2.3. Product Portfolio
    • 9.2.4. Business Strategies
    • 9.2.5. Recent Developments
  • 9.3. Deltagen, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Overview
    • 9.3.3. Product Portfolio
    • 9.3.4. Business Strategies
    • 9.3.5. Recent Developments
  • 9.4. genOway S.A.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Overview
    • 9.4.3. Product Portfolio
    • 9.4.4. Business Strategies
    • 9.4.5. Recent Developments
  • 9.5. Harbour Antibodies BV
    • 9.5.1. Company Overview
    • 9.5.2. Financial Overview
    • 9.5.3. Product Portfolio
    • 9.5.4. Business Strategies
    • 9.5.5. Recent Developments
  • 9.6. Harlan Laboratories, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Overview
    • 9.6.3. Product Portfolio
    • 9.6.4. Business Strategies
    • 9.6.5. Recent Developments
  • 9.7. ImmunoGenes AG
    • 9.7.1. Company Overview
    • 9.7.2. Financial Overview
    • 9.7.3. Product Portfolio
    • 9.7.4. Business Strategies
    • 9.7.5. Recent Developments
  • 9.8. SAGE Labs
    • 9.8.1. Company Overview
    • 9.8.2. Financial Overview
    • 9.8.3. Product Portfolio
    • 9.8.4. Business Strategies
    • 9.8.5. Recent Developments
  • 9.9. The Jackson Laboratory
    • 9.9.1. Company Overview
    • 9.9.2. Financial Overview
    • 9.9.3. Product Portfolio
    • 9.9.4. Business Strategies
    • 9.9.5. Recent Developments
  • 9.10. Taconic Biosciences, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Overview
    • 9.10.3. Product Portfolio
    • 9.10.4. Business Strategies
    • 9.10.5. Recent Developments
  • 9.11. TransGenic, Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Financial Overview
    • 9.11.3. Product Portfolio
    • 9.11.4. Business Strategies
    • 9.11.5. Recent Developments

List of Figures

  • FIG. 1: Global Mice Model Market Segmentation
  • FIG. 2: Global Mice Model Market, By Type, 2014 (USD Million)
  • FIG. 3: Global Mice Model Market, By Application, 2014 (USD Million)
  • FIG. 4: Global Mice Model Market, By Services, 2014 (USD Million)
  • FIG. 5: Comparative Analysis: Global Mice Model Market Revenue, by Geography, 2014 and 2023E (Value %)
  • FIG. 6: Biomedical Research Growth Rate, 2007-2012, (%)
  • FIG. 7: Mice Model Market Analysis: The U.S. and China, 2014
  • FIG. 8: Market Attractiveness Analysis: Global Mice Model Market, by Geography
  • FIG. 9: Growth-Share Matrix Analysis: Global Mice Model Market, by Type
  • FIG. 10: Market Share Analysis: Global Mice Model Market, 2013 (Value %)
  • FIG. 11: Market Share Analysis: Global Mice Model Market, 2014 (Value %)
  • FIG. 12: Heat Map Analysis, by Key Geography, 2014 (Market Share)
  • FIG. 13: Heat Map Analysis, by Key Geography, 2014 (Market Growth)
  • FIG. 14: Transgenic Mice Applications in Various Specialties (%), 2014
  • FIG. 15: Transgenic Mice Model Market, 2013-2023E (USD Million)
  • FIG. 16: Hybrid/Congenic Mice Model Market, 2013-2023E (USD Million)
  • FIG. 17: Knockout Mice Applications in Various Specialties, 2014 (%)
  • FIG. 18: Knockout Mice Model Market, 2013-2023E (USD Million)
  • FIG. 19: Carcinogen-induced and Spontaneous Mice Model Market, 2013-2023E (USD Million)
  • FIG. 20: Outbred Mice Model Market, 2013-2023E (USD Million)
  • FIG. 21: Inbred Mice Applications in various Specialties (%), 2014
  • FIG. 22: Inbred Mice Model Market, 2013-2023E (USD Million)
  • FIG. 23: Transplantation Mice Model Market, 2013-2023E (USD Million)
  • FIG. 24: Conditioned/Surgically Modified Mice Model Market, 2013-2023E (USD Million)
  • FIG. 25: Immunology Mice Models Market, 2013-2023E (USD Million)
  • FIG. 26: Immunology Mice Models, by Major Companies
  • FIG. 27: Immunology Mice Model Market Share, by Model Type, 2014
  • FIG. 28: Immunology Mice Models Market, 2013-2023E (USD Million)
  • FIG. 29: Number of CNS Mice Models, by Major Companies
  • FIG. 30: Mice Model Market Share, by Model Type, 2014
  • FIG. 31: Oncology Mice Models Market, 2013-2023E (USD Million)
  • FIG. 32: Number of CNS Mice Models, by Major Companies
  • FIG. 33: Oncology Mice Model Market Share, by Model Type, 2014
  • FIG. 34: Cardiovascular Mice Models Market, 2013-2023E (USD Million)
  • FIG. 35: Number of CNS Mice Models, by Major Companies
  • FIG. 36: Cardiovascular Mice Model Market Share, by Model Type, 2014
  • FIG. 37: Diabetes Mice Models Market, 2013-2023E (USD Million)
  • FIG. 38: Number of Diabetes Mice Models, by Major Companies
  • FIG. 39: Diabetes Mice Model Market Share, by Model Type, 2014
  • FIG. 40: Metabolism & Regulation Mice Models Market, 2013-2023E (USD Million)
  • FIG. 41: Metabolism & Regulation Mice Models Market Share, by Model Type, 2014
  • FIG. 42: Global Breeding and Rederivation Services Market, 2013-2023E (USD Million)
  • FIG. 43: Global Cryopreservation and Cryorecovery Services Market, 2013-2023E (USD Million)
  • FIG. 44: Global Quarantine Services Market, 2013-2023E (USD Million)
  • FIG. 45: Global Genetic Testing Services Market, 2013-2023E (USD Million)
  • FIG. 46: Global Model In-licensing Market, 2013-2023E (USD Million)
  • FIG. 47: Global In vivo and In vitro Pharmacology Services Market, 2013-2023E (USD Million)
  • FIG. 48: Genetically Engineered Model Services
  • FIG. 49: Global Other Services Market, 2013-2023E (USD Million)
  • FIG. 50: Mice Model Market Share Index, 2014 (On Scale of 1 to 5)
  • FIG. 51: Global Mice Model Market, Growth Index, 2015-2023 (On a Scale of 1 to 5)
  • FIG. 52: U.S. Mice Model Market, 2013-2023E (USD Million)
  • FIG. 53: Comparative Analysis: Proportion of Animals Used in Research in Canada, 2011 and 2012 (Value %)
  • FIG. 54: Canada Mice Model Market, 2013-2023E (USD Million)
  • FIG. 55: Germany Mice Model Market Revenue, 2013-2023E (USD Million)
  • FIG. 56: U.K. Mice Model Market Revenue, 2013-2023E (USD Million)
  • FIG. 57: Rest of Europe Market Revenue, 2013-2023E (USD Million)
  • FIG. 58: Japan Mice Model Market, 2013-2023E (USD Million)
  • FIG. 59: China Mice Model Market, 2013-2023E (USD Million)
  • FIG. 60: Rest of Asia Pacific Mice Model Market, 2013-2023E (USD Million)
  • FIG. 61: Brazil Mice Model Market, 2013-2023E (USD Million)
  • FIG. 62: Mexico Mice Model Market, 2013-2023E (USD Million)
  • FIG. 63: Rest of Latin America Mice Model Market, 2013-2023E (USD Million)
  • FIG. 64: Saudi Arabia Mice Model Market, 2013 - 2023E (USD Million)
  • FIG. 65: UAE Mice Model Market, 2013-2023E (USD Million)
  • FIG. 66: Israel Mice Model Market, 2013-2023E (USD Million)
  • FIG. 67: Rest of MENA Mice Model Market, 2013-2023E (USD Million)
  • FIG. 68: Rest of World Mice Model Market, 2013-2023E (USD Million)
  • FIG. 69: Charles River Laboratories International, Inc.: Annual Revenue, 2012-2014 (USD Million)
  • FIG. 70: Charles River Laboratories International, Inc.: Business Segments
  • FIG. 71: Charles River Laboratories International, Inc.: Financials, 2012-2014
  • FIG. 72: Deltagen, Inc.: Annual Revenue, 2012-2014 (USD Million)
  • FIG. 73: Deltagen, Inc.: Financials, 2012-2014 (USD Million)
  • FIG. 74: genOway S.A.: Annual Revenue, 2012-2014 (USD Million)
  • FIG. 75: genOway S.A.: Financials, 2012-2014 (USD Million)
  • FIG. 76: The Jackson Laboratory: Annual Revenue, 2012-2014 (USD million)
  • FIG. 77: The Jackson Laboratory: Financials, 2012-2014 (USD million)
  • FIG. 78: TransGenic, Inc.: Annual Revenue, 2012-2014 (USD million)
  • FIG. 79: TransGenic, Inc.: Financials, 2012-2014 (USD million)

List of Tables

  • TABLE 1: Global Mice Consumption, 2013
  • TABLE 2: Market Snapshot: Global Mice Model Market (2014 and 2023E )
  • TABLE 3: Proportion of Mice as Compared to Total Animal Used in Research Globally (Value %), 2011
  • TABLE 4: End-user Analysis of Mice Model Market (Value %), 2013
  • TABLE 5: Global Mice Model Market, by Type, 2013-2014 (USD Million)
  • TABLE 6: Global Mice Model Market, by Model Type, 2015E-2023E (USD Million)
  • TABLE 7: Global Mice Model Market, by Application, 2013-2014 (USD Million)
  • TABLE 8: Global Mice Model Market, by Application, 2015E-2023E (USD Million)
  • TABLE 9: Global Mice Model Market, by Services, 2013-2014 (USD Million)
  • TABLE 10: Global Mice Model Market, by Services, 2015E-2023E (USD Million)
  • TABLE 11: Global Mice Model Market Revenue, by Geography, 2013-2023 (USD Million)
  • TABLE 12: North America Population, GDP, and Health care Expenditure, 2011-2013
  • TABLE 13: Europe Population, GDP, and Health care Expenditure, 2011-2013
  • TABLE 14: Europe Mice Model Market Revenue, 2013-2023E (USD Million)
  • TABLE 15: Asia Pacific Population, GDP, and Healthcare Expenditure, 2011-2013
  • TABLE 16: Asia Pacific Mice Model Market Revenue, 2013-2023E (USD Million)
  • TABLE 17: Latin America Population, GDP, and Health care Expenditure, 2011-2013
  • TABLE 18: Latin America Mice Model Market, 2013-2023E (USD Million)
  • TABLE 19: MENA Mice Model Market, 2013-2023E (USD Million)
  • TABLE 20: Row Population, GDP, and Health care Expenditure, 2011-2013
Back to Top